503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
10.87%
Net income growth under 50% of ZETA's 40.68%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
19.27%
Some D&A expansion while ZETA is negative at -1.61%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-4013.33%
Negative yoy deferred tax while ZETA stands at 53.19%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
9.10%
SBC growth well above ZETA's 10.68%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-25.63%
Negative yoy working capital usage while ZETA is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-137.79%
Both yoy AR lines negative, with ZETA at -367.30%. Martin Whitman would suspect an overall sector lean approach or softer demand.
230.57%
Inventory growth of 230.57% while ZETA is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
122.35%
AP growth well above ZETA's 224.45%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
24.39%
Lower 'other working capital' growth vs. ZETA's 100.00%. David Dodd would see fewer unexpected short-term demands on cash.
-8.19%
Both negative yoy, with ZETA at -192.80%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-45.51%
Negative yoy CFO while ZETA is 20.83%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
8.09%
CapEx growth well above ZETA's 14.14%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-103066.67%
Both yoy lines negative, with ZETA at -26.79%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
18.20%
Purchases growth of 18.20% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
40.80%
Liquidation growth of 40.80% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
1373.81%
We have some outflow growth while ZETA is negative at -39.54%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
20.14%
We have mild expansions while ZETA is negative at -18.84%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-1730.22%
We cut debt repayment yoy while ZETA is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-45.64%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
17.49%
We have some buyback growth while ZETA is negative at -23.83%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.